Embecta (EMBC) Cash & Equivalents (2022 - 2026)
Embecta's Cash & Equivalents came in at $214.7 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 6.9% from $230.6 million a year earlier but up 16.1% from the prior quarter.
Powered by 
Analysis
Embecta (EMBC) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Embecta's Cash & Equivalents was $225.5 million, down 15.7% from FY2024.
- Cash & Equivalents has declined in each of the last three fiscal years, with a three-year compound annual growth rate of -12.0% (FY2022 to FY2025).
- Going back by fiscal year, Cash & Equivalents was $267.5 million in FY2024 (-18.0%), $326.3 million in FY2023 (-1.4%) and $330.9 million in FY2022.
- The five-year range for quarterly Cash & Equivalents is $184.9 million (fiscal Q2 2026) to $385.2 million (fiscal Q1 2023).
- Year-over-year, Cash & Equivalents has declined for 12 consecutive quarters, with an average decline of 16.6% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q2 2023 (growth of 31.1%), and the weakest in fiscal Q2 2025 (a decline of 30.2%).
- Business Quant data shows EMBC's Cash & Equivalents at $184.9 million (Q2 2026), $201.3 million (Q1 2026) and $225.5 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.71 Bn | 229.74 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 178.38 Bn | 148.81 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 161.61 Bn | 145.42 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 154.15 Bn | 134.44 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 123.21 Bn | 88.46 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 117.50 Bn | 103.61 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 67.50 Bn | 62.26 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Becton Dickinson | 54.80 Bn | 51.95 Bn | 2.32 Bn | 708.00 Mn |
| 9 | Edwards Lifesciences | 51.78 Bn | 35.79 Bn | 1.35 Bn | 2.91 Bn |
| 10 | Embecta | 398.83 Mn | -427.57 Mn | 153.30 Mn | 214.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 214.70 Mn |
| Mar 31, 2026 | 184.90 Mn |
| Dec 31, 2025 | 201.30 Mn |
| Sep 30, 2025 | 225.50 Mn |
| Jun 30, 2025 | 230.60 Mn |
| Mar 31, 2025 | 209.30 Mn |
| Dec 31, 2024 | 210.00 Mn |
| Sep 30, 2024 | 267.50 Mn |
| Jun 30, 2024 | 275.10 Mn |
| Mar 31, 2024 | 299.80 Mn |
| Dec 31, 2023 | 298.70 Mn |
| Sep 30, 2023 | 326.30 Mn |
| Jun 30, 2023 | 317.40 Mn |
| Mar 31, 2023 | 346.40 Mn |
| Dec 31, 2022 | 385.20 Mn |
| Sep 30, 2022 | 330.90 Mn |
| Jun 30, 2022 | 292.30 Mn |
| Mar 31, 2022 | 264.30 Mn |
API Access
Embecta Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EMBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EMBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EMBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();